Store
The World Market for Diagnostic Biomarkers, 2021
Publication Date: April 6, 2021
Tags: Cardiovascular Disease, Diagnostic Instruments, Immunoassay, Infectious Diseases, Neurological Diseases, Oncology and Cancer
Pages: 135
SKU: 21-017
Kalorama Information’s The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, Autoimmune, Others), 2021 provides an authoritative and comprehensive analysis of the global biomarker market from 2015 to 2024, with 2020 as the base year. This report covers the diverse applications of biomarkers in diagnostics, including disease diagnosis, prognosis prediction, therapy selection, disease monitoring, and more.
Market Segments:
The report offers detailed market data across key clinical diagnostic biomarker segments, including:
- Cancer Biomarkers: Evaluation of tumor markers and their role in cancer diagnosis and management.
- Cardiovascular Disease Biomarkers: Analysis of biomarkers for heart disease and vascular disorders.
- Immunological Disease Biomarkers: Insights into biomarkers for autoimmune diseases and allergies.
- Infectious Disease Biomarkers: Overview of biomarkers used to detect and manage infectious diseases.
- Neurological Disease Biomarkers: Examination of biomarkers for diseases affecting the nervous system.
- Other Disease Biomarkers: Coverage of biomarkers for various other conditions including bone diseases, renal diseases, and more.
Industry Trends and Innovations:
Understand the drivers of growth in the biomarker market, including:
- Aging Population: Increasing susceptibility to diseases in older populations.
- Targeted Therapies: Rise in the development and introduction of targeted therapies.
- Expanding Diagnostic Test Market: Growth in the clinical diagnostic test market fueling biomarker development.
- Technological Advances: Emerging technologies such as mass spectrometry, next-generation DNA sequencing, and bioinformatics.
Market Analysis:
Explore the global landscape of the biomarker market with a focus on:
- Total Global Clinical Diagnostic Biomarker Market: Market forecasts and growth rates for various disease segments from 2015 to 2025.
- Segment Analysis: Detailed data on market segments by disease and technology, highlighting the share of each segment.
Personalized and Precision Medicine:
Delve into the role of biomarkers in the evolution of personalized and precision medicine:
- Pharmacogenomics and Pharmacogenetics: Growth of companion diagnostics and their integration into clinical practice.
- Automation and Innovation: Advances in instrumentation and the introduction of new biomarker tests.
- Reimbursement Trends: Increasing acceptance and coverage for new biomarker-based diagnostics by healthcare payers.
Competitor Analysis:
Gain insights into key players in the biomarker market, including:
- Top Tier IVD Companies: Profiles of leading companies in the biomarker space.
- Specialized Biomarker Companies: Detailed reviews of companies focused on specific biomarker technologies and applications.
Detailed Company Profiles:
The report includes extensive profiles of companies active in the biomarker market, ranging from large multinationals to innovative startups. These profiles cover:
- Commercialized Products: Overview of products available in the market and in development.
- Key Technologies: Technologies used for biomarker detection and analysis, including immunoassays, PCR, microarrays, and more.
Table: Global Biomarker Sales, by Product Group & Region, 2018-2027 (million dollars)
| Item/Year | 2018 | 2020 | 2022 | 2027 | CAGR (18-27) |
| Product Groups | |||||
| Infectious Diseases | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Cancer | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Cardiovascular | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Clinical Chemistry | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Neurological | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Autoimmune | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Other | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Regions | |||||
| North America | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Western Europe | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Asia/Pacific | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Central & South America | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Eastern Europe | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Middle East | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Africa | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
Table of Contents
Chapter 1: Introduction
- Report Coverage
- Methodology
- Sources of Information
Chapter 2: Executive Summary
-
- Table 2-1: Summary Table: Global Biomarker Sales by Product Group & Region (million dollars), 2018-2027 (Product Groups: Infectious Diseases, Cancer, Cardiovascular, Clinical Chemistry, Neurological, Autoimmune, and Other & Regions: North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, Middle East, and Africa)
Chapter 3: Market Environment & Analysis
- Overview
- Demographic Patterns
- World Healthcare Trends
- Table 3-1: Global Demographic & Healthcare Indicators, 2018-2027 (World Population, Healthcare Expenditures, Healthcare Resources, and Healthcare Activity)
- Biomarker Technologies
- Biomarker Market Analysis
- Biomarker Products
- Table 3-2: Global Biomarker Sales by Product Group (million dollars), 2018-2027 (Infectious, Cancer, Cardiovascular, Clinical Chemistry, Neurological, Autoimmune, and Other)
- Figure 3-1: 2020 Global Biomarker Product Sales by Type ) ($43.0 million), (Infectious, Cancer, Cardiovascular, Clinical Chemistry, Neurological, Autoimmune, and Other
- Geographical Markets
- Table 3-3: Global Infectious Disease Biomarker Sales by Region (million dollars), 2018-2027 (U.S., Canada, Mexico, Asia Pacific, China, Japan, Western Europe, Eastern Europe, Central America, South America, and Africa and the Middle East)
- Figure 3-2: Biomarker Product Sales by Major Geographical Market, 2020 ($43.04 billion), (U.S., Canada, Mexico, Asia Pacific, China, Japan, Western Europe, Eastern Europe, Central America, South America, and Africa and the Middle East)
- Biomarker Products
Chapter 4: Infectious Disease Biomarkers
- Overview
- Table 4-1: Global Infectious Disease Biomarker Sales by Major Product Group (million dollars), 2018-2027 (Respiratory, HAIs, Hepatitis, HIV, STDs, TORCH, and Other)
- Infectious Disease Biomarker Technologies
- Table 4-2: Global Infectious Disease Biomarker Sales by Technology (million dollars), 2018-2027 (Lab Immunoassay Tests, Molecular Tests, and Rapid Immunoassay Tests)
- COVID-19 Biomarkers
- Table 4-3: COVID-19 Tests by Type, 2020 and 2021, (millions) (Molecular, Antigen, and Antibody)
- Table 4-4: Global COVID-19 Test Sales by Type, 2020 and 2021 (million dollars) (Molecular, Antigen, and Antibody)
- Table 4-5: Major COVID-19 Test Vendors by Category, unranked
- Respiratory Diseases
- Table 4-6: Global Respiratory Disease Biomarker Sales by Condition (million dollars), 2018-2027 (Pneumonia, Influenza, Group Strep A, Tuberculosis, and Other)
- Figure 4-1: Respiratory Disease Biomarker Product Sales Breakdown by Condition, 2020 (Pneumonia, Influenza, Strep A, Tuberculosis, and Other)
- Table 4-7: Global Respiratory Disease Biomarker Sales by Technology (million dollars), 2018-2027 (Laboratory Immunoassay, Molecular, and POC)
- Pneumonia
- Influenza
- Group A Streptococcus Infections
- Tuberculosis
- Other Respiratory Infections
- Healthcare-Associated Infections (HAIs)
- Table 4-8: Global Healthcare-Associated Infections (HAIs) Biomarker Sales by Type (million dollars), 2018-2027 (C. diff, Sepsis, Staph, Enterococci, and Other)
- Clostridioides difficile (c. diff)
- Sepsis
- Staphylococcus aureus
- Enterococcus
- Other Healthcare-Associated Infections
- Table 4-8: Global Healthcare-Associated Infections (HAIs) Biomarker Sales by Type (million dollars), 2018-2027 (C. diff, Sepsis, Staph, Enterococci, and Other)
- Hepatitis
- Types of Hepatitis
- Hepatitis Biomarkers
- Table 4-9: Global Hepatitis Biomarker Sales by Type (million dollars), 2018-2027 (Hepatitis B, Hepatitis C, and Other Types)
- Commercial Hepatitis Tests
- HIV
- Overview
- Statistical Trends
- Biomarker-Based HIV Tests
- Table 4-10: Global HIV Biomarker Sales by Technology (million dollars), 2018-2027 (Immunoassay, Molecular, and Rapid POC)
- Commercial HIV Tests
- Sexually Transmitted Diseases (STDs)
- Table 4-11: Global STD Biomarker Sales by Type (million dollars), 2018-2027 (HPV, CT/NG, Trichomoniasis, HSV 1&2, and Other)
- Human Papillomavirus (HPV)
- Chlamydia/Gonorrhea (CT/NG)
- Trichomoniasis
- Herpes Simplex Virus (HSV-1 & HSV-2)
- Table 4-12: Producers of Herpes Simplex Virus Tests
- Other Sexually Transmitted Diseases
- Table 4-11: Global STD Biomarker Sales by Type (million dollars), 2018-2027 (HPV, CT/NG, Trichomoniasis, HSV 1&2, and Other)
- TORCH
- Table 4-13: Global TORCH Biomarker Sales (million dollars), 2018-2027
- Other Infectious Diseases
- Table 4-14: Global Other Infectious Disease Biomarker Sales by Type (million dollars), 2018-2027 (Malaria, Lyme Disease, E. Coli, H. pylori, Dengue, and All Other)
- Malaria
- Lyme Disease
- coli
- pylori
- Dengue
- All Other Disease
- Table 4-14: Global Other Infectious Disease Biomarker Sales by Type (million dollars), 2018-2027 (Malaria, Lyme Disease, E. Coli, H. pylori, Dengue, and All Other)
Chapter 5: Cancer Biomarkers
- Overview
- Types of Cancer Biomarkers
- Table 5-1: Global Cancer Biomarker Sales by Type (million dollars), 2018-2027 (CTMs and TTMs)
- Market Analysis
- Table 5-2: Global Cancer Biomarker Sales by Condition (million dollars), 2018-2027 (Breast, Prostate, Lung, Colorectal, Melanoma, Bladder, Uterine, Non-Hodgkin Lymphoma, Kidney, Leukemias, Pancreatic, Thyroid, Liver, Multiple Myeloma, Stomach, Ovarian, Esophageal, and All Other)
- Biomarker Product Suppliers
Chapter 6: Cardiovascular Biomarkers
- Overview
- Key Biomarkers
- Market Analysis
- Table 6-1: Global Cardiovascular Biomarker Sales by Product Group (million dollars), 2018-2027 (Coagulation, CAD, CHF, MI, Cerebrovascular, Atherosclerosis, Cholesterol/Lipid, and Other)
- Biomarker Product Suppliers
Chapter 7: Clinical Chemistry Biomarkers
- Overview
- Blood Gases & Electrolytes
- Urinanalysis
- Workstation Immunoassay Tests
- Market Analysis
- Table 7-1: Global Clinical Chemistry Biomarker Sales by Product Group (million dollars), 2018-2027 (Glucose, Electrolytes, Cardiac Biomarkers, Enzymes, HbA1c, Proteins, Drugs of Abuse, Therapeutic Drugs, and Other)
- Biomarker Product Suppliers
Chapter 8: Neurological Biomarkers
- Overview
- Key Biomarkers
- Market Analysis
- Table 8-1: Global Neurological Biomarker Sales by Product Group (million dollars), 2018-2027 (Alzheimer’s Disease, Neuropathy Disorders, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, and Other)
- Biomarker Product Suppliers
Chapter 9: Autoimmune Biomarkers
- Overview
- Key Biomarkers
- Market Analysis
- Table 9-1: Global Autoimmune Biomarker Sales by Product Group (million dollars), 2018-2027 (Hashimoto’s Thyroiditis, Rheumatoid Arthritis, Type 1 Diabetes, Celiac Disease, Ulcerative Colitis, SLE, Crohn’s Disease, and Other)
- Biomarker Product Suppliers
Chapter 10: Other Biomarkers
- Overview
- Table 10-1: Other Global Biomarker Sales by Product Group (million dollars), 2018-2027 (Diabetes & Metabolic, Fertility & Pregnancy, Kidney Disorders, Inherited Diseases, Thyroid Conditions, and All Other)
- Diabetes & Metabolic Biomarkers
- Fertility & Pregnancy Biomarkers
- Kidney Disorders
- Inherited Diseases
- Cystic Fibrosis
- Down Syndrome
- Sickle Cell Disease
- Gaucher Disease
- Familial Hypercholesterolemia
- Muscular Dystrophy
- Hemophilia
- Von Willebrand Disease
- Neurofibromatosis
- Polycystic Kidney Disease
- Spinal Muscle Atrophy
- Klinefelter Syndrome
- Canavan disease
- Cerebral Palsy
- Angelman Syndrome (AS)
- Other Inherited Diseases
- Thyroid Conditions
- All Other Biomarkers
- Bone Disease Biomarkers
- Gastrointestinal Biomarkers
- Respiratory Biomarkers
Chapter 11: Company Profiles
-
- Table 11-1: IVD Biomarker-Related Sales of Selected Industry Leaders, 2020 (million dollars) (Roche Diagnostics, Abbott Diagnostics, Danaher, Thermo Fisher Scientific, Siemens Healthineers, Becton Dickinson, bioMérieux, Illumina, Ortho Clinical Diagnostics, Quidel, Exact Sciences, Bio-Rad Laboratories, DiaSorin Group, Myriad Genetics, and Luminex)
- Roche Diagnostics (Basel, Switzerland)
- Molecular Testing
- Companion Diagnostics
- Circulating Tumor Cells
- Abbott Diagnostics (Abbott Park, Illinois)
- COVID-19
- Point-of-Care Tests
- Core Laboratory
- Molecular Assays
- Companion Diagnostics
- Liquid Biopsy
- Danaher Corporation (Washington, D.C.)
- Cepheid
- Radiometer
- Beckman Coulter
- Leica Biosystems
- Thermo Fisher Scientific (Waltham, Massachusetts)
- Siemens Healthineers (Malvern, Pennsylvania)
- Becton Dickinson, and Company – BD (Franklin Lakes, New Jersey)
- bioMérieux (Marcy l’Etoile, France)
- Illumina (San Diego, California)
- Ortho Clinical Diagnostics (Raritan, New Jersey)
- Quidel Corporation (San Diego, California)
- Exact Sciences (Madison, Wisconsin)
- Bio-Rad Laboratories (Hercules, California)
- DiaSorin Group (Saluggia, Italy)
- Myriad Genetics (Salt Lake City, Utah)
- Luminex Corporation (Austin, Texas)
Related products
COVID-19 Testing Markets, 2023
May 18, 2023
As the COVID-19 pandemic evolves into an endemic phase, the landscape of COVID-19 testing is changing rapidly. Kalorama Information’s COVID-19 Testing Markets, 2023 report provides crucial insights into this shifting market, answering key questions and providing valuable market sizing and estimates.
Key Insights Provided:
- Market impacts and trends in the evolving COVID-19 testing…
Price range: $4,000.00 through $6,000.00
In Vitro Diagnostic (IVD) Trends and Market Update: March 2024
March 26, 2024
Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.
The report offers updated data analysis based on Kalorama Information’s annual…
Price range: $5,000.00 through $7,875.00
The World Market for Veterinary Diagnostics, 7th Edition
January 22, 2024
Unlock the potential of the veterinary diagnostics market with Kalorama Information’s comprehensive report, The World Market for Veterinary Diagnostics, 7th Edition, which dives deep into the world of animal healthcare diagnostics. From disease identification to monitoring, veterinarians rely on a variety of tests for accurate diagnoses and effective treatment plans. Our report provides a detailed…
Price range: $5,000.00 through $7,875.00
